How Cancer Drug Doxorubicin induces Cardiotoxicity

Doxorubicin is a highly effective anticancer agent but causes cardiotoxicity in many patients. The mechanisms of doxorubicin-induced cardiotoxicity remain incompletely understood. In a recent Nature Scientific Report, Liqun Zhao and Baolin Zhang from the U.S. Food and Drug Administration provided compelling evidence that doxorubicin-induced upregulation of death receptors in cardiomyocytes leads to spontaneous apoptosis which is exacerbated by physiologically relevant concentrations of death ligands such as TRAIL. 

The complete publication can be viewed here.  

Figure: A working model by which doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocyte by Springer Nature under CC-BY-4.0

 

 

 
 

Passende Artikel

xCELLigence CARDIO

xCELLigence CARDIO  system is a high-resolution system, utilizing non-invasive impedance readout for real time monitoring of functional beating activity of cardiomyocytes in the wells of E-Plate CARDIO 96. The application range of the xCELLigence system will be extended to the important field of preclinical cardiac safety assessment, cardiac drug screening and basic research. A Ingenious Solution for  in vitro  Cardiac...

Preis auf Anfrage

2801009

 
 

Kommentar schreiben

 

Die mit einem * markierten Felder sind Pflichtfelder.